AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 45 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $950,000 | -66.8% | 500,000 | +181.6% | 0.20% | -47.8% |
Q2 2019 | $2,858,000 | -52.9% | 177,546 | -8.0% | 0.39% | -29.4% |
Q1 2019 | $6,074,000 | -8.9% | 192,994 | -4.9% | 0.55% | -26.2% |
Q4 2018 | $6,666,000 | -25.4% | 202,994 | -31.5% | 0.75% | -26.8% |
Q3 2018 | $8,935,000 | +89.5% | 296,251 | +68.3% | 1.03% | +57.8% |
Q2 2018 | $4,716,000 | – | 176,045 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $40,558,975 | 64.38% |
TFG Asset Management GP Ltd | 8,300,000 | $15,770,000 | 2.26% |
Odey Asset Management Group Ltd | 2,499,400 | $4,748,860 | 1.43% |
Deep Track Capital, LP | 15,000,000 | $28,500,000 | 1.20% |
Nantahala Capital Management | 7,782,018 | $14,785,834 | 0.96% |
DAFNA Capital Management LLC | 1,176,150 | $2,234,685 | 0.63% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $7,119,028 | 0.44% |
ARMISTICE CAPITAL, LLC | 10,224,000 | $19,425,600 | 0.34% |
CVI Holdings, LLC | 1,237,511 | $2,351,271 | 0.30% |
HARBOR CAPITAL ADVISORS, INC. | 145,315 | $276,099 | 0.27% |